Intravitreal aflibercept (IVT-AFL) for macular edema secondary to CRVO: Results of COPERNICUS and GALILEO studies

被引：0
|
作者：
Creuzot, C. [1 ]
机构：
[1] Dept Ophthalmol, Djon, France
来源：
ACTA OPHTHALMOLOGICA | 2013年 / 91卷
关键词：
D O I：
10.1111/j.1755-3768.2013.4714.x
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
4714
引用
收藏
页数：2
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS OF INTRAVITREAL AFLIBERCEPT (IVT-AFL) IN TREATMENT OF MACULAR EDEMA (ME) SECONDARY TO BRANCH RETINAL VEIN OCCLUSION (BRVO)
    Sar, C.
    Malhan, S.
    Oksuz, E.
    Eldem, B.
    Unlu, N.
    Alp, M. N.
    Ozmert, E.
    Durukan, A. H.
    Erdal, E.
    Kahveci, B.
    VALUE IN HEALTH, 2016, 19 (07) : A568 - A568
  • [2] THE COST-EFFECTIVENESS (CE) OF INTRAVITREAL AFLIBERCEPT (IVT-AFL) IN THE TREATMENT OF DIABETIC MACULAR EDEMA (DME) IN TURKEY
    Deger, C.
    Ozdemir, O.
    Eldem, B.
    Unlu, N.
    Alp, M. N.
    Saatci, A. O.
    Ozmert, E.
    Altintas, A. K.
    Sermet, F.
    Erdal, E.
    Sar, C.
    Asan, S.
    Sumer, F.
    Parali, E.
    Ozel, O.
    VALUE IN HEALTH, 2015, 18 (07) : A606 - A606
  • [3] Intravitreal Aflibercept (IVT-AFL) for Diabetic Macular Edema (DME): 3 Year Data from VIVID-DME and VISTA-DME
    Staurenghi, G.
    Metzig, C.
    ACTA OPHTHALMOLOGICA, 2015, 93
  • [4] Rapid Response to Intravitreal Aflibercept (IVT-AFL) in Patients with Diabetic Macular Edema (DME) in the Vivid-dme and Vista-DME Trials
    Varano, Monica
    Korobelnik, Jean-Francois
    Parravano, Mariacristina
    Katz, Todd A.
    Metzig, Carola
    OPHTHALMOLOGICA, 2014, 232 : 22 - 22
  • [5] Impact of Intravitreal Aflibercept (IVT-AFL) on Diabetic Retinopathy in the VIVID-DME and VISTA-DME Studies
    Larsen, L. M.
    Metzig, C.
    ACTA OPHTHALMOLOGICA, 2015, 93
  • [6] COST-MINIMIZATION ANALYSIS OF INTRAVITREAL AFLIBERCEPT (IVT-AFL) FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION IN SPAIN
    Garcia-Layana, A.
    Ortega, A.
    Ruiz-Moreno, J. M.
    Figueroa, M. S.
    Farres, J.
    Mendivil, J.
    Altemark, A.
    Wittrup-Jensen, K. U.
    VALUE IN HEALTH, 2013, 16 (07) : A507 - A507
  • [7] Two-Year Results of the COPERNICUS Study Evaluating Intravitreal Aflibercept Injection (IAI) for Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO)
    Clark, W. Lloyd
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [8] Rescue Therapy Use in Patients with Diabetic Macular Edema (DME) Receiving Intravitreal Aflibercept (IVT-AFL) or Laser: Results from the VIVID-DME and VISTA-DME Trials
    Rehak, Matus
    Korobelnik, Jean-Francois
    Metzig, Carola
    OPHTHALMOLOGICA, 2014, 232 : 17 - 18
  • [9] THE COST-EFFECTIVENESS OF INTRAVITREAL AFLIBERCEPT (IVT-AFL) IN TREATING NEOVASCULAR AGE-RELATED MACULAR DEGENERATION IN AN ITALIAN SETTING
    D'Ausilio, A.
    Midena, E.
    Pilotto, E.
    Calligari, N.
    Bianchi, C.
    Wittrup-Jensen, K. U.
    VALUE IN HEALTH, 2013, 16 (07) : A505 - A505
  • [10] Eighteen-Month Results of the GALILEO Study Evaluating Intravitreal Aflibercept Injection (IAI) for Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO)
    Ogura, Yuichiro
    Korobelnik, Jean-Francois
    Roider, Johann
    Vitti, Robert
    Holz, Frank
    Hiemeyer, Florian
    Stemper, Brigitte
    Zeitz, Oliver
    Sandbrink, Rupert
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
12345